This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
13
Check minimum number of events None
13
Include endpoints None
13
Remove individuals based on genotype QC
13
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Myoclonus, drug-induced based on the number of shared cases.
Broader endpoints:
- Other extrapyramidal and movement disorders in other diseases
- Extrapyramidal and movement disorders
- Neurological diseases
- Neurological diseases
- Factors influencing health status and contact with health services
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 13 | 7 | 6 |
Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
Mean age at first event (years) | 40.67 | 29.23 | 54.01 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: MYOCLONUS – Myoclonus, drug-induced
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Myoclonus, drug-induced
↥Endpoint not on priority list, no data to show.